Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis

• Main Authors: Benedicto Crespo-Facorro (Author), Miguel Ruiz-Veguilla (Author), Javier Vázquez-Bourgon (Author), Ana C. Sánchez-Hidalgo (Author), Nathalia Garrido-Torres (Author), Jose M. Cisneros (Author), Carlos Prieto (Author), Jesus Sainz (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Antipsychotics modulate expression of inflammatory cytokines and inducible inflammatory enzymes. Elopiprazole (a phenylpiperazine antipsychotic drug in phase 1) has been characterized as a therapeutic drug to treat SARS-CoV-2 infection in a repurposing study. We aim to investigate the po...